Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Zika Diagnostic Could Rapidly Detect The Virus

XTALKS VITALS NEWS

Diagnostic Device

The latest research combines the RNA detection system with a CRISPR-based module to create a freeze-dried diagnostic for the Zika virus. Image: Wyss Institute at Harvard University.

Share this!

May 10, 2016 | by Sarah Massey, M.Sc.

The details of a paper-based prototype diagnostic device used to detect the Zika virus, have been published in the journal, Cell. The portable device was able to identify the virus in the blood and saliva of infected monkeys.

The Aedes mosquito is the primary vector responsible for transmitting the Zika virus to humans. Though the majority of those that become infected show only mild symptoms, the virus has been connected to cases of microcephaly in newborns, as well as other serious birth defects.

Because of the virus’ potential to compromise prenatal health and development in pregnant women that become infected with Zika, researchers are frantically trying to develop better diagnostic tests to control the spread of the outbreak. Among these researchers are James Collins, of the Wyss Institute for Biologically Inspired Engineering at Harvard University in Boston and his colleagues, who have developed a test capable of detecting small amounts of the Zika virus in multiple biological samples.

The researchers previously published the details of paper-based diagnostic utilizing sensors capable of detecting nucleic acids characteristic of Ebola and other RNA viruses. The latest research combines the RNA detection system with a CRISPR-based module to create a freeze-dried diagnostic for the Zika virus.



The test produces a colour change in the presence of the Zika virus. When the device was used to test blood and saliva samples taken from Zika-positive monkeys, the colourimetric detection was functional, even at low concentrations of the virus.

The study investigators caution that the device is only in the proof of concept stage. With the right resources however, they say the diagnostic could be ready for clinical use in just a few months.

As current diagnostics sometimes misidentify other viruses related to Zika, the researchers hope this tool could be more reliable. Because the test is portable, it could also help aid workers screen for the virus in areas that are without a centralized hospital or testing facility.

“The test's low cost and minimal equipment also means that it can be used for monitoring the spread of illnesses across large populations of people, enabling us to monitor the pathogen as an outbreak is occurring,” said Collins. “NGOs [non-governmental organizations] like the World Health Organization (WHO) can use this information to get ahead of an outbreak in order to contain it and save lives.”


Keywords: Zika Virus, Diagnostic Device, World Health Organization


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Food Companies are Looking for the Next Sriracha

October 19, 2017 - The Sriracha trend might be coming to an end and companies are looking for the next big hot sauce star to feature in their line-up.

Featured In: Food News


CFIA Recalling Mechanically Tenderized Steaks in Canada for E. coli

October 19, 2017 - The Canadian Food Inspection Agency posted a recall for mechanically tenderized steaks at the request of Vantage Foods Inc. on Tuesday.

Featured In: Food News


Study: Gender May Be Important When Matching Blood Transfusion Recipients to Donors

October 19, 2017 - According to a new study published in JAMA, gender and a history of pregnancy among female donors may have an impact on how well blood donors and recipients can be matched.

Featured In: Life Science News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Five Reasons Why Toronto is Emerging as a Major Life Sciences Hub

REGISTER FOR THESE WEBINARS

Brexit – Separating Fact from Fiction


Evolving Best Practices for Working with Authors of Scientific Publications – Authorship and Beyond


Human Whole-Genome Sequencing in a New Era Defined by the Illumina® HiSeq X® and NovaSeq™ Platforms


Clinical Event Adjudication: Comprehensive and Efficient Dossier Review Using a Global On-Line Solution


Copyright © 2016-2017 Honeycomb Worldwide Inc.